The specific inhibition of HDAC3 has been shown to decrease the deposition of Aβ1-42 and the phosphorylation of tau protein and increase BDNF mRNA expression in the 3xTg-AD mouse model [20]. This evidence concerns the gene MAPT and Alzheimer disease.